A leading supplier of drug testing kits recently revealed an updated screening panel that excludes cannabis testing and places a greater emphasis on fentanyl detection. Psychemedics, a company based in Massachusetts known for manufacturing the first commercially viable hair drug test in 1986, announced on Friday the launch of a new five-panel drug screen.